Health-care companies ticked up as traders rotated into defensive sectors.
U.S. health regulators are expected to weigh in soon on the evidence for giving the Covid-19 vaccine from Pfizer and BioNTech to children 5 to 11 years old. Company data indicates the vaccine is effective among younger children.
A study conducted by testing firm Theranos on cancer patients showed huge variations between the subjects in the study, but Theranos failed to adequately explain why there was this variation, a former Pfizer scientist testified Friday in the case of Elizabeth Holmes.
Write to Rob Curran at rob.curran@dowjones.com
(END) Dow Jones Newswires
10-22-21 1659ET
